These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38140179)

  • 1.
    Gilfillan D; Vilander AC; Pan M; Goh YJ; O'Flaherty S; Feng N; Fox BE; Lang C; Greenberg HB; Abdo Z; Barrangou R; Dean GA
    Vaccines (Basel); 2023 Nov; 11(12):. PubMed ID: 38140179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homotypic protection against rotavirus-induced diarrhea in infant mice breast-fed by dams immunized with the recombinant VP8* subunit of the VP4 capsid protein.
    Gil MT; de Souza CO; Asensi M; Buesa J
    Viral Immunol; 2000; 13(2):187-200. PubMed ID: 10892999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune response and protective efficacy of the S particle presented rotavirus VP8* vaccine in mice.
    Xia M; Huang P; Jiang X; Tan M
    Vaccine; 2019 Jul; 37(30):4103-4110. PubMed ID: 31201052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Particle-bombardment-mediated DNA vaccination with rotavirus VP4 or VP7 induces high levels of serum rotavirus IgG but fails to protect mice against challenge.
    Choi AH; Basu M; Rae MN; McNeal MM; Ward RL
    Virology; 1998 Oct; 250(1):230-40. PubMed ID: 9770437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective efficacy of rotavirus 2/6-virus-like particles combined with CT-E29H, a detoxified cholera toxin adjuvant.
    Siadat-Pajouh M; Cai L
    Viral Immunol; 2001; 14(1):31-47. PubMed ID: 11270595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and characterization of a novel truncated rotavirus VP4 for the development of a recombinant rotavirus vaccine.
    Li Y; Xue M; Yu L; Luo G; Yang H; Jia L; Zeng Y; Li T; Ge S; Xia N
    Vaccine; 2018 Apr; 36(16):2086-2092. PubMed ID: 29555220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological response to recombinant VP8* subunit protein of bovine roravirus in pregnant cattle.
    Lee J; Babiuk LA; Harland R; Gibbons E; Elazhary Y; Yoo D
    J Gen Virol; 1995 Oct; 76 ( Pt 10)():2477-83. PubMed ID: 7595351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parenterally Administered P24-VP8* Nanoparticle Vaccine Conferred Strong Protection against Rotavirus Diarrhea and Virus Shedding in Gnotobiotic Pigs.
    Ramesh A; Mao J; Lei S; Twitchell E; Shiraz A; Jiang X; Tan M; Yuan AL
    Vaccines (Basel); 2019 Nov; 7(4):. PubMed ID: 31698824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VP8* antigen produced in tobacco transplastomic plants confers protection against bovine rotavirus infection in a suckling mouse model.
    Lentz EM; Mozgovoj MV; Bellido D; Dus Santos MJ; Wigdorovitz A; Bravo-Almonacid FF
    J Biotechnol; 2011 Nov; 156(2):100-7. PubMed ID: 21893114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tandem truncated rotavirus VP8* subunit protein with T cell epitope as non-replicating parenteral vaccine is highly immunogenic.
    Wen X; Cao D; Jones RW; Hoshino Y; Yuan L
    Hum Vaccin Immunother; 2015; 11(10):2483-9. PubMed ID: 26091081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral immunization of mice with Lactococcus lactis expressing the rotavirus VP8* protein.
    Rodríguez-Díaz J; Montava R; Viana R; Buesa J; Pérez-Martínez G; Monedero V
    Biotechnol Lett; 2011 Jun; 33(6):1169-75. PubMed ID: 21302132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lactobacilli and Bifidobacteria enhance mucosal B cell responses and differentially modulate systemic antibody responses to an oral human rotavirus vaccine in a neonatal gnotobiotic pig disease model.
    Kandasamy S; Chattha KS; Vlasova AN; Rajashekara G; Saif LJ
    Gut Microbes; 2014; 5(5):639-51. PubMed ID: 25483333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production and characterization of murine IgA monoclonal antibodies to the surface antigens of rhesus rotavirus.
    Giammarioli AM; Mackow ER; Fiore L; Greenberg HB; Ruggeri FM
    Virology; 1996 Nov; 225(1):97-110. PubMed ID: 8918537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of rotavirus NSP4 protein on the immune response and protection of the S
    Liu C; Huang P; Zhao D; Xia M; Zhong W; Jiang X; Tan M
    Vaccine; 2021 Jan; 39(2):263-271. PubMed ID: 33309483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humoral immune responses to VP4 and its cleavage products VP5* and VP8* in infants vaccinated with rhesus rotavirus.
    Padilla-Noriega L; Fiore L; Rennels MB; Losonsky GA; Mackow ER; Greenberg HB
    J Clin Microbiol; 1992 Jun; 30(6):1392-7. PubMed ID: 1320626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal or oral immunization of inbred and outbred mice with murine or human rotavirus VP6 proteins protects against viral shedding after challenge with murine rotaviruses.
    Choi AH; McNeal MM; Basu M; Flint JA; Stone SC; Clements JD; Bean JA; Poe SA; VanCott JL; Ward RL
    Vaccine; 2002 Sep; 20(27-28):3310-21. PubMed ID: 12213401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a bivalent recombinant vaccine candidate targeting norovirus and rotavirus: Antibodies to rotavirus NSP4 exert antidiarrheal effects without virus neutralization.
    Cao H; Wu J; Luan N; Wang Y; Lin K; Liu C
    J Med Virol; 2022 Aug; 94(8):3847-3856. PubMed ID: 35474320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant porcine rotavirus VP4 and VP4-LTB expressed in Lactobacillus casei induced mucosal and systemic antibody responses in mice.
    Qiao X; Li G; Wang X; Li X; Liu M; Li Y
    BMC Microbiol; 2009 Dec; 9():249. PubMed ID: 19958557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody-independent protection against rotavirus infection of mice stimulated by intranasal immunization with chimeric VP4 or VP6 protein.
    Choi AH; Basu M; McNeal MM; Clements JD; Ward RL
    J Virol; 1999 Sep; 73(9):7574-81. PubMed ID: 10438847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction and immunogenicity of the recombinant Lactobacillus acidophilus pMG36e-E0-LA-5 of bovine viral diarrhea virus.
    Zhao Y; Jiang L; Liu T; Wang M; Cao W; Bao Y; Qin J
    J Virol Methods; 2015 Dec; 225():70-5. PubMed ID: 26386184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.